RECRUITING

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Talk to us

Conditions

Smoking Cessationcigarettesmokingcanceranxietystresstobaccomindfulness

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Official Title

Reducing Distress and Tobacco Smoking in Cancer Survivors: a TDCS Telehealth Study

Quick Facts

Study Start:2023-08-15
Study Completion:2025-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05460676

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 21-75 years old
  2. * smoke ≥10 cigarettes per day
  3. * mild to moderate distress (K10 scores 10-35)
  4. * access to a reliable internet connection
  5. * all prescription medications stable for ≥ 1 month prior to enrollment and throughout the trial, and approved by the Study Physician
  1. * Current suicidal ideation
  2. * Current use of smoking cessation medication (e.g., varenicline)
  3. * Current use of inhaled products (other than cigarettes) which may influence exhaled carbon monoxide measures (e.g. smoking cannabis, vaping)
  4. * History of seizure disorder, recent (\<5 years) seizure history, cerebrovascular accident, neurodegenerative disease, or traumatic brain injury
  5. * Currently receiving chemotherapy or radiation
  6. * Presence of metal objects in the head/neck
  7. * Any skin disorder or skin sensitive area near stimulation locations

Contacts and Locations

Study Contact

Hilary R Smith
CONTACT
336-716-5181
hsmith@wakehealth.edu

Principal Investigator

Merideth A Addicott, Ph.D.
PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences

Study Locations (Sites)

Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Merideth A Addicott, Ph.D., PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-15
Study Completion Date2025-01

Study Record Updates

Study Start Date2023-08-15
Study Completion Date2025-01

Terms related to this study

Keywords Provided by Researchers

  • cigarette
  • smoking
  • cancer
  • anxiety
  • stress
  • tobacco
  • mindfulness

Additional Relevant MeSH Terms

  • Smoking Cessation